-
1 Comment
Stereotaxis, Inc is currently in a long term uptrend where the price is trading 51.3% above its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 18.8.
Stereotaxis, Inc's total revenue sank by 1.0% to $7M since the same quarter in the previous year.
Its net income has dropped by 8.9% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 116.0% to $308K since the same quarter in the previous year.
Based on the above factors, Stereotaxis, Inc gets an overall score of 3/5.
ISIN | US85916J4094 |
---|---|
CurrencyCode | USD |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Exchange | NYSE MKT |
Market Cap | 171M |
---|---|
PE Ratio | None |
Target Price | 4.5 |
Beta | 1.6 |
Dividend Yield | None |
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for STXS using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025